Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond. Hematol Oncol Stem Cell Ther. 2019.
Whole body lung function test-derived outcome predictors in allogenic stem cell transplantation. Biol Blood Marrow Transplant. 2018..
Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020.
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157-e167.
Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant. 2018.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. Transplant Cell Ther. 2021.
Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor. Transplantation. 2016..
Impact of smoking behavior on survival following allogeneic hematopoietic stem cell transplantation - smoking cessation matters. Nicotine Tob Res. 2021..
Epidermal Elafin Expression is an Indicator of Poor Prognosis in Cutaneous Graft-versus-Host Disease. J Invest Dermatol. 2014.
Diverse T cell responses characterize the different manifestations of cutaneous graft-versus-host disease. Blood. 2013.